Immutep Ltd (IMM) - Total Assets

Latest as of June 2025: AU$156.98 Million AUD ≈ $111.08 Million USD

Based on the latest financial reports, Immutep Ltd (IMM) holds total assets worth AU$156.98 Million AUD (≈ $111.08 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check how aggressively does Immutep Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Immutep Ltd - Total Assets Trend (2000–2025)

This chart illustrates how Immutep Ltd's total assets have evolved over time, based on quarterly financial data. Check Immutep Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.

Immutep Ltd - Asset Composition Analysis

Current Asset Composition (June 2025)

Immutep Ltd's total assets of AU$156.98 Million consist of 95.0% current assets and 5.0% non-current assets.

Asset Category	Amount (AUD)	% of Total Assets
Cash & Equivalents	AU$17.26 Million	42.9%
Accounts Receivable	AU$7.46K	0.0%
Inventory	AU$0.00	0.0%
Property, Plant & Equipment	AU$569.48K	0.4%
Intangible Assets	AU$7.09 Million	4.5%
Goodwill	AU$109.96K	0.1%

Asset Composition Trend (2000–2025)

This chart illustrates how Immutep Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Immutep Ltd (IMM) market capitalisation.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Immutep Ltd's current assets represent 95.0% of total assets in 2025, an increase from 0.0% in 2000.
Cash Position: Cash and equivalents constituted 42.9% of total assets in 2025, up from 32.8% in 2000.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 4.0% of total assets, an increase from 0.0% in 2000.
Asset Diversification: The largest asset category is cash and equivalents at 42.9% of total assets.

Immutep Ltd Competitors by Total Assets

Key competitors of Immutep Ltd based on total assets are shown below.

Company	Country	Total Assets
Revolution Medicines Inc NASDAQ:RVMD	USA	$2.25 Billion
Tubize-Fin BR:TUB	Belgium	€1.93 Billion
Metsera, Inc. Common Stock NASDAQ:MTSR	USA	$639.66 Million
Hugel Inc KQ:145020	Korea	₩1.13 Trillion
Bicara Therapeutics Inc. Common Stock NASDAQ:BCAX	USA	$553.60 Million
Sinopep-Allsino Biopharmaceutical Co. Ltd. A SHG:688076	China	CN¥6.82 Billion
Absci Corp NASDAQ:ABSI	USA	$195.59 Million
Shenzhen Weiguang Biological Products Co Ltd SHE:002880	China	CN¥3.67 Billion

Immutep Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	11.69	18.25	9.26
Quick Ratio	11.69	18.25	9.26
Cash Ratio	1.35	6.38	4.02
Working Capital	AU$136.34 Million	AU$180.86 Million	AU$27.79 Million

Immutep Ltd - Advanced Valuation Insights

This section examines the relationship between Immutep Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	3.79
Latest Market Cap to Assets Ratio	0.35
Asset Growth Rate (YoY)	-22.1%
Total Assets	AU$156.98 Million
Market Capitalization	$55.20 Million USD

Valuation Analysis

Below Book Valuation: The market values Immutep Ltd's assets below their book value (0.35x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Immutep Ltd's assets decreased by 22.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Immutep Ltd (2000–2025)

The table below shows the annual total assets of Immutep Ltd from 2000 to 2025.

Year	Total Assets	Change
2025-06-30	AU$156.98 Million ≈ $111.08 Million	-22.12%
2024-06-30	AU$201.58 Million ≈ $142.63 Million	+36.71%
2023-06-30	AU$147.45 Million ≈ $104.33 Million	+44.32%
2022-06-30	AU$102.17 Million ≈ $72.29 Million	+24.55%
2021-06-30	AU$82.03 Million ≈ $58.04 Million	+76.04%
2020-06-30	AU$46.60 Million ≈ $32.97 Million	+14.94%
2019-06-30	AU$40.54 Million ≈ $28.69 Million	-13.74%
2018-06-30	AU$47.00 Million ≈ $33.25 Million	+34.42%
2017-06-30	AU$34.96 Million ≈ $24.74 Million	-17.84%
2016-06-30	AU$42.55 Million ≈ $30.11 Million	+37.34%
2015-06-30	AU$30.98 Million ≈ $21.92 Million	+22.09%
2014-06-30	AU$25.38 Million ≈ $17.96 Million	-22.66%
2013-06-30	AU$32.81 Million ≈ $23.22 Million	-21.14%
2012-06-30	AU$41.61 Million ≈ $29.44 Million	-27.81%
2011-06-30	AU$57.64 Million ≈ $40.78 Million	+203.19%
2010-06-30	AU$19.01 Million ≈ $13.45 Million	+663.62%
2009-06-30	AU$2.49 Million ≈ $1.76 Million	-11.75%
2008-06-30	AU$2.82 Million ≈ $2.00 Million	-35.27%
2007-06-30	AU$4.36 Million ≈ $3.08 Million	-40.78%
2006-06-30	AU$7.36 Million ≈ $5.21 Million	-19.40%
2005-06-30	AU$9.13 Million ≈ $6.46 Million	+58.31%
2004-06-30	AU$5.77 Million ≈ $4.08 Million	+45.36%
2003-06-30	AU$3.97 Million ≈ $2.81 Million	-33.04%
2002-06-30	AU$5.93 Million ≈ $4.19 Million	+39.63%
2001-06-30	AU$4.24 Million ≈ $3.00 Million	+102.58%
2000-06-30	AU$2.10 Million ≈ $1.48 Million	--

About Immutep Ltd

AU:IMM Australia Biotechnology

Market Cap

$55.20 Million

AU$78.01 Million AUD

Market Cap Rank

#21574 Global

#761 in Australia

Share Price

AU$0.05

Change (1 day)

+8.16%

52-Week Range

AU$0.04 - AU$0.46

All Time High

AU$0.68